Filing Flows

Filing Flows › Marimed (MRMD) › How it makes money

How Marimed (MRMD) makes money

Marimed (MRMD) made $41.9M of revenue in the second quarter 2026 (Q2 2026), +6% from a year earlier. Product sales - retail brought in $23.2M (55%); Product sales - wholesale brought in $18.5M (44%); Other revenue brought in $193K (0%).

Drawing the Sankey…

Marimed revenue by segment, Q2 2026Marimed revenue by segment, Q2 2026Product sales - retail$23.2MProduct sales - wholesale$18.5MOther revenue$193K
Marimed: revenue by line, Q1 2025 to Q2 2026Marimed: revenue by line, Q1 2025 to Q2 2026Product sales - retailProduct sales - whole…Other revenueProduct sales - retail: $23.2M latest$23.2MProduct sales - wholesale: $18.5M latest$18.5MOther revenue: $193K latestQ1 2025Q2 2025Q3 2025Q1 2026Q2 2026
The mix barely moved between Q1 2025 and Q2 2026.
Marimed revenue by quarterMarimed revenue by quarter$38.9MQ4 2024$37.9MQ1 2025$39.5MQ2 2025$40.8MQ3 2025$41.6MQ4 2025$39.5MQ1 2026$41.9MQ2 2026
Marimed: where each dollar of revenue goesMarimed: where each dollar of revenue goesIncome tax5¢Operating cash flow5¢Free cash flow5¢

Revenue by segment, Q2 2026

SegmentRevenueShareQ/QY/Y
Product sales - retail$23.2M55.4%+7%+4%
Product sales - wholesale$18.5M44.2%+6%+8%
Other revenue$193K0.5%-19%+371%

Where each dollar of revenue goes

LineQ2 2026% of revenue
Revenue$41.9M100.0%
Income tax$2.0M4.8%
Operating cash flow$2.2M5.3%
Free cash flow$1.9M4.6%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q2 2026$41.9M+6%
Q1 2026$39.5M+4%
Q4 2025$41.6M+7%
Q3 2025$40.8M+0.4%
Q2 2025$39.5M-2%
Q1 2025$37.9M-0.1%
Q4 2024$38.9M+0.1%

From Marimed's 10-Q filed Aug 13, 2026 (on EDGAR).

Questions

How does Marimed make money?

Marimed (MRMD) made $41.9M of revenue in the second quarter 2026 (Q2 2026), +6% from a year earlier. Product sales - retail brought in $23.2M (55%); Product sales - wholesale brought in $18.5M (44%); Other revenue brought in $193K (0%).

What is Marimed's biggest business?

Product sales - retail: $23.2M in the second quarter 2026, 55% of revenue, +4% from a year earlier.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.